Group 5 metabotropic glutamate receptors: Role in modulating cortical activity and relevance to cognition

European Journal of Pharmacology

Volumn 639, Issue 1-3, 2010, Pages 33-39

  Homayoun, Houman ^a   Moghaddam, Bita ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive enhancer; Metabotropic glutamate receptor 5; NMDA glutamate receptor; Prefrontal cortex; Schizophrenia

Indexed keywords

(4 FLUOROPHEYL) {3 {3 (4 FLUOROPHENYL) [1,2,4] OXADIAZOL 5 YL}PIPERIDIN 1 YL}METHANONE); 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 3 CYANO N (1,3 DIPHENYL 1H PYRAZOL 5 YL)BENZAMIDE; 3,3' DIFLUOROBENZALDAZINE; CLOZAPINE; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT;

ALLOSTERISM; BEHAVIOR; BRAIN CORTEX; BRAIN ELECTROPHYSIOLOGY; CELL ACTIVITY; COGNITION; DRUG EFFECT; LONG TERM DEPRESSION; NERVE CELL PLASTICITY; NERVE CONDUCTION; NEUROPHYSIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; CLASSIFICATION; DRUG EFFECTS; HUMAN; METABOLISM; PHYSIOLOGY; PREFRONTAL CORTEX;

ANIMALS; ANTIPSYCHOTIC AGENTS; COGNITION; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; PREFRONTAL CORTEX; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTOR, METABOTROPIC GLUTAMATE 5;

EID: 77953615107     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.12.042     Document Type: Review

References (97)

1. Alagarsamy S., Marino M.J., Rouse S.T., Gereau R.W.T., Heinemann S.F., Conn P.J. Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Nat. Neurosci. 1999, 2:234-240.
2. Ango F., Pin J.P., Tu J.C., Xiao B., Worley P.F., Bockaert J., Fagni L. Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by homer1 proteins and neuronal excitation. J. Neurosci. 2000, 20:8710-8716.
3. Ango F., Prezeau L., Muller T., Tu J.C., Xiao B., Worley P.F., Pin J.P., Bockaert J., Fagni L. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature 2001, 411:962-965.
4. Attucci S., Albani-Torregrossa S., Moroni F., Pellegrini-Giampietro D.E. Metabotropic glutamate receptors stimulate phospholipase D via different pathways in the adult and neonate rat hippocampus. Neurochem. Res. 2001, 26:1151-1155.
5. Awad H., Hubert G.W., Smith Y., Levey A.I., Conn P.J. Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. J. Neurosci. 2000, 20:7871-7879.
6. Ayala J.E., Chen Y., Banko J.L., Sheffler D.J., Williams R., Telk A.N., Watson N.L., Xiang Z., Zhang Y., Jones P.J., Lindsley C.W., Olive M.F., Conn P.J. mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology 2009, 34:2057-2071.
7. Balschun D., Wetzel W. Inhibition of mGluR5 blocks hippocampal LTP in vivo and spatial learning in rats. Pharmacol. Biochem. Behav. 2002, 73:375-380.
8. Balschun D., Manahan-Vaughan D., Wagner T., Behnisch T., Reymann K.G., Wetzel W. A specific role for group I mGluRs in hippocampal LTP and hippocampus-dependent spatial learning. Learn. Mem. 1999, 6:138-152.
9. Balschun D., Zuschratter W., Wetzel W. Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory. Neuroscience 2006, 142:691-702.
10. Baude A., Nusser Z., Roberts J.D., Mulvihill E., McIlhinney R.A., Somogyi P. The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron 1993, 11:771-787.
11. Bear M.F. Therapeutic implications of the mGluR theory of fragile X mental retardation. Genes Brain Behav. 2005, 4:393-398.
12. Bear M.F., Huber K.M., Warren S.T. The mGluR theory of fragile X mental retardation. Trends Neurosci. 2004, 27:370-377.
13. Behnisch T., Reymann K.G. Co-activation of metabotropic glutamate and N-methyl-d-aspartate receptors is involved in mechanisms of long-term potentiation maintenance in rat hippocampal CA1 neurons. Neuroscience 1993, 54:37-47.
14. Bell M.I., Richardson P.J., Lee K. Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneurones. J. Neurochem. 2002, 81:142-149.
15. Bikbaev A., Neyman S., Ngomba R.T., Conn J., Nicoletti F., Manahan-Vaughan D. MGluR5 mediates the interaction between late-LTP, network activity, and learning. PLoS One 2008, 3:e2155.
16. Camodeca N., Breakwell N.A., Rowan M.J., Anwyl R. Induction of LTD by activation of group I mGluR in the dentate gyrus in vitro. Neuropharmacology 1999, 38:1597-1606.
17. Campbell U., Lalwani K., Hernandez L., Kinney G., Conn P., Bristow L. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. Psychopharmacology (Berl) 2004, 175:310-318.
18. Chan M.H., Chiu P.H., Sou J.H., Chen H.H. Attenuation of ketamine-evoked behavioral responses by mGluR5 positive modulators in mice. Psychopharmacology (Berl) 2008, 198:141-148.
19. Chuang S.C., Zhao W., Bauchwitz R., Yan Q., Bianchi R., Wong R.K. Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J. Neurosci. 2005, 25:8048-8055.
20. Conn P.J., Lindsley C.W., Jones C.K. Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol. Sci. 2009, 30:25-31.
21. Contractor A., Gereau R.W.T., Green T., Heinemann S.F. Direct effects of metabotropic glutamate receptor compounds on native and recombinant N-methyl-d-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:8969-8974.
22. Cooper D.C. The significance of action potential bursting in the brain reward circuit. Neurochem. Int. 2002, 41:333-340.
23. Coyle J. The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev. Psychiatry 1996, 3:241-253.
24. Darrah J.M., Stefani M.R., Moghaddam B. Interaction of N-methyl-d-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm. Behav. Pharmacol. 2008, 19:225-234.
25. Devilbiss D.M., Berridge C.W. Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness. Biol. Psychiatry 2008, 64:626-635.
26. Doherty A.J., Palmer M.J., Henley J.M., Collingridge G.L., Jane D.E. (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology 1997, 36:265-267.
27. Faas G.C., Adwanikar H., Gereau R.W.T., Saggau P. Modulation of presynaptic calcium transients by metabotropic glutamate receptor activation: a differential role in acute depression of synaptic transmission and long-term depression. J. Neurosci. 2002, 22:6885-6890.
28. Fendt M., Schmid S. Metabotropic glutamate receptors are involved in amygdaloid plasticity. Eur. J. Neurosci. 2002, 15:1535-1541.
29. Fitzjohn S., Kingston A., Lodge D., Collingridge G. DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists. Neuropharmacology 1999, 38:1577-1583.
30. Gasparini F., Lingenhohl K., Stoehr N., Flor P.J., Heinrich M., Vranesic I., Biollaz M., Allgeier H., Heckendorn R., Urwyler S., Varney M.A., Johnson E.C., Hess S.D., Rao S.P., Sacaan A.I., Santori E.M., Velicelebi G., Kuhn R. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 1999, 38:1493-1503.
31. Gasparini F., Kuhn R., Pin J.P. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr. Opin. Pharmacol. 2002, 2:43-49.
32. Gereau R.W.T., Heinemann S.F. Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5. Neuron 1998, 20:143-151.
33. Henry S.A., Lehmann-Masten V., Gasparini F., Geyer M.A., Markou A. The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity. Neuropharmacology 2002, 43:1199-1209.
34. Homayoun H., Moghaddam B. Bursting of prefrontal cortex neurons in awake rats is regulated by metabotropic glutamate 5 (mGlu5) receptors: rate-dependent influence and interaction with NMDA receptors. Cereb. Cortex 2006, 16:93-105.
35. Homayoun H., Moghaddam B. Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine. J. Neurosci. 2006, 26:8025-8039.
36. Homayoun H., Moghaddam B. Fine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine. Biol. Psychiatry 2007, 61:679-687.
37. Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J. Neurosci. 2007, 27:11496-11500.
38. Homayoun H., Moghaddam B. Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18041-18046.
39. Homayoun H., Stefani M.R., Adams B.W., Tamagan G.D., Moghaddam B. Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release. Neuropsychopharmacology 2004, 29:1259-1269.
40. Homayoun H., Jackson M.E., Moghaddam B. Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. J. Neurophysiol. 2005, 93:1989-2001.
41. Huang C.C., Hsu K.S. Sustained activation of metabotropic glutamate receptor 5 and protein tyrosine phosphatases mediate the expression of (S)-3, 5-dihydroxyphenylglycine-induced long-term depression in the hippocampal CA1 region. J. Neurochem. 2006, 96:179-194.
42. Huber K.M., Roder J.C., Bear M.F. Chemical induction of mGluR5- and protein synthesis-dependent long-term depression in hippocampal area CA1. J. Neurophysiol. 2001, 86:321-325.
43. Huber K.M., Gallagher S.M., Warren S.T., Bear M.F. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:7746-7750.
44. Jia Z., Lu Y., Henderson J., Taverna F., Romano C., Abramow-Newerly W., Wojtowicz J., Roder J. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Learn. Mem. 1998, 5:331-343.
45. Jong Y.J., Kumar V., Kingston A.E., Romano C., O'Malley K.L. Functional metabotropic glutamate receptors on nuclei from brain and primary cultured striatal neurons. Role of transporters in delivering ligand. J. Biol. Chem. 2005, 280:30469-30480.
46. Kaneoke Y., Vitek J.L. Burst and oscillation as disparate neuronal properties. J. Neurosci. Methods 1996, 68:211-223.
47. Kinney G., Burno M., Campbell U., Hernandez L., Rodriguez D., Bristow L., Conn P. Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents. J. Pharmacol. Exp. Ther. 2003, 306:116-123.
48. Kinney G.G., O'Brien J.A., Lemaire W., Burno M., Bickel D.J., Clements M.K., Chen T.B., Wisnoski D.D., Lindsley C.W., Tiller P.R., Smith S., Jacobson M.A., Sur C., Duggan M.E., Pettibone D.J., Conn P.J., Williams D.L. A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. J. Pharmacol. Exp. Ther. 2005, 313:199-206.
49. Knoflach F., Mutel V., Jolidon S., Kew J.N., Malherbe P., Vieira E., Wichmann J., Kemp J.A. Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13402-13407.
50. Krystal J.H., Abi-Saab W., Perry E., D'Souza D.C., Liu N., Gueorguieva R., McDougall L., Hunsberger T., Belger A., Levine L., Breier A. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology (Berl) 2005, 179:303-309.
51. Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci. Biobehav. Rev. 2002, 26:91-104.
52. Lauterborn J.C., Rex C.S., Kramar E., Chen L.Y., Pandyarajan V., Lynch G., Gall C.M. Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. J. Neurosci. 2007, 27:10685-10694.
53. Lecourtier L., Homayoun H., Tamagnan G., Moghaddam B. Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-d-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. Biol. Psychiatry 2007, 62:739-746.
54. Lee A.C., Wong R.K., Chuang S.C., Shin H.S., Bianchi R. Role of synaptic metabotropic glutamate receptors in epileptiform discharges in hippocampal slices. J. Neurophysiol. 2002, 88:1625-1633.
55. Lewis D.A., Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch. Neurol. 2006, 63:1372-1376.
56. Liu, F., Zhang, G., Hornby, G., Vasylyev, D., Bowlby, M., Park, K., Gilbert, A., Marquis, K., Andree, T.H., 2006. The effect of mGlu5 receptor positive allosteric modulators on signaling molecules in brain slices. Eur. J. Pharmacol. 536, 262-268.
57. Liu F., Grauer S., Kelley C., Navarra R., Graf R., Zhang G., Atkinson P.J., Popiolek M., Wantuch C., Khawaja X., Smith D., Olsen M., Kouranova E., Lai M., Pruthi F., Pulicicchio C., Day M., Gilbert A., Pausch M.H., Brandon N.J., Beyer C.E., Comery T.A., Logue S., Rosenzweig-Lipson S., Marquis K.L. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1, 2, 4]-oxadiazol-5-yl]-piper idin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities. J. Pharmacol. Exp. Ther. 2008, 327:827-839.
58. Lu Y.M., Jia Z., Janus C., Henderson J.T., Gerlai R., Wojtowicz J.M., Roder J.C. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J. Neurosci. 1997, 17:5196-5205.
59. Lujan R., Nusser Z., Roberts J.D., Shigemoto R., Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. Eur. J. Neurosci. 1996, 8:1488-14500.
60. Manahan-Vaughan D., Braunewell K.H. The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cereb. Cortex 2005, 15:1703-1713.
61. Manahan-Vaughan D., Schuetz K. Differential participation of metabotropic glutamate receptor mGlu1 and mGlu5 in spatial learning and hippocampal long-term potentiation in vivo. Neuropharmacology 2002, 43:297.
62. Mannaioni G., Marino M.J., Valenti O., Traynelis S.F., Conn P.J. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J. Neurosci. 2001, 21:5925-5934.
63. Mao L., Wang J.Q. Glutamate cascade to cAMP response element-binding protein phosphorylation in cultured striatal neurons through calcium-coupled group I metabotropic glutamate receptors. Mol. Pharmacol. 2002, 62:473-484.
64. Mao L., Wang J.Q. Interactions between ionotropic and metabotropic glutamate receptors regulate cAMP response element-binding protein phosphorylation in cultured striatal neurons. Neuroscience 2002, 115:395-402.
65. Mao L.M., Zhang G.C., Liu X.Y., Fibuch E.E., Wang J.Q. Group I metabotropic glutamate receptor-mediated gene expression in striatal neurons. Neurochem. Res. 2008, 33:1920-1924.
66. Marino M.J., Conn P.J. Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors. Curr. Opin. Pharmacol. 2006, 6:98-102.
67. Marino M.J., Wittmann M., Bradley S.R., Hubert G.W., Smith Y., Conn P.J. Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata. J. Neurosci. 2001, 21:7001-7012.
68. Merlin L. Differential roles for mGluR1 and mGluR5 in the persistent prolongation of epileptiform bursts. J. Neurophysiol. 2002, 87:621-625.
69. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003, 40:881-884.
70. Moghaddam B. Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology (Berl) 2004, 174:39-44.
71. Moghaddam B., Homayoun H. Dopamine and glutamate hypotheses of schizophrenia. Contemporary Neuropharmacology 2007, Vol. 2:283-320. P. John Wiley and Sons, Hoboken, NJ. D.R. Sibley, I. Hanin, M. Kuhar, Skolnick (Eds.).
72. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 1997, 17:2921-2927.
73. Naie K., Manahan-Vaughan D. Regulation by metabotropic glutamate receptor 5 of LTP in the dentate gyrus of freely moving rats: relevance for learning and memory formation. Cereb. Cortex 2004, 14:189-198.
74. Neyman S., Manahan-Vaughan D. Metabotropic glutamate receptor 1 (mGluR1) and 5 (mGluR5) regulate late phases of LTP and LTD in the hippocampal CA1 region in vitro. Eur. J. Neurosci. 2008, 27:1345-1352.
75. O'Brien J.A., Lemaire W., Chen T.B., Chang R.S., Jacobson M.A., Ha S.N., Lindsley C.W., Schaffhauser H.J., Sur C., Pettibone D.J., Conn P.J., Williams D.L. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5. Mol. Pharmacol. 2003, 64:731-740.
76. 2+ changes in heterologous cell types and neurons. J. Biol. Chem. 2003, 278:28210-28219.
77. Ostlund S., Balleine B. Lesions of medial prefrontal cortex disrupt the acquisition but not the expression of goal-directed learning. J. Neurosci. 2005, 25:7763-7770.
78. Patil S.T., Zhang L., Martenyi F., Lowe S.L., Jackson K.A., Andreev B.V., Avedisova A.S., Bardenstein L.M., Gurovich I.Y., Morozova M.A., Mosolov S.N., Neznanov N.G., Reznik A.M., Smulevich A.B., Tochilov V.A., Johnson B.G., Monn J.A., Schoepp D.D. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat. Med. 2007, 13:1102-1107.
79. Pisani A., Calabresi P., Centonze D., Bernardi G. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones. Br. J. Pharmacol. 1997, 120:1007-1014.
80. Pisani A., Gubellini P., Bonsi P., Conquet F., Picconi B., Centonze D., Bernardi G., Calabresi P. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-d-aspartate responses in medium spiny striatal neurons. Neuroscience 2001, 106:579-587.
81. Rodrigues S.M., Bauer E.P., Farb C.R., Schafe G.E., LeDoux J.E. The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala. J. Neurosci. 2002, 22:5219-5229.
82. Romano C., Sesma M., McDonald C.T., O'Malley K., Van den Pol A.N., Olney J.W. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J. Comp. Neurol. 1995, 355:455-469.
83. Semenova S., Markou A. The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task. Neuropharmacology 2007, 52:863-872.
84. Shigemoto R., Nomura S., Ohishi H., Sugihara H., Nakanishi S., Mizuno N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci. Lett. 1993, 163:53-57.
85. Sourdet V., Russier M., Daoudal G., Ankri N., Debanne D. Long-term enhancement of neuronal excitability and temporal fidelity mediated by metabotropic glutamate receptor subtype 5. J. Neurosci. 2003, 23:10238-10248.
86. Spooren W.P., Gasparini F., Bergmann R., Kuhn R. Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats. Eur. J. Pharmacol. 2000, 406:403-410.
87. Stefani M.R., Moghaddam B. Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility and working memory includes by NMDA receptor blockade. Eur. J. Pharmacol. 2010, 639:26-32. (this issue).
88. Stoop R., Conquet F., Zuber B., Voronin L., Pralong E. Activation of metabotropic glutamate 5 and NMDA receptors underlies the induction of persistent bursting and associated long-lasting changes in CA3 recurrent connections. J. Neurosci. 2003, 23:5634-5644.
89. Tamminga C.A. Schizophrenia and glutamatergic transmission. Crit. Rev. Neurobiol. 1998, 12:21-36.
90. Tanaka J., Nakagawa S., Kushiya E., Yamasaki M., Fukaya M., Iwanaga T., Simon M.I., Sakimura K., Kano M., Watanabe M. Gq protein alpha subunits Galphaq and Galpha11 are localized at postsynaptic extra-junctional membrane of cerebellar Purkinje cells and hippocampal pyramidal cells. Eur. J. Neurosci. 2000, 12:781-792.
91. Wang X.F., Daw N.W. Long term potentiation varies with layer in rat visual cortex. Brain Res. 2003, 989:26-34.
92. Williams D.L., Lindsley C.W. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5). Curr. Top. Med. Chem. 2005, 5:825-846.
93. Wilson B.M., Cox C.L. Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2454-2459.
94. Winterer G., Weinberger D. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 2004, 27:683-690.
95. Wu M., Hajszan T., Xu C., Leranth C., Alreja M. Group I metabotropic glutamate receptor activation produces a direct excitation of identified septohippocampal cholinergic neurons. J. Neurophysiol. 2004, 92:1216-1225.
96. Xu J., Zhu Y., Contractor A., Heinemann S.F. mGluR5 has a critical role in inhibitory learning. J. Neurosci. 2009, 29:3676-3684.
97. 2+-independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neurons. J. Neurosci. 2004, 24:10846-10857.